Ruxolitinib Best for Glucocorticoid-Refractory, -Dependent GVHD
Overall response, failure-free survival, symptom response significantly greater with ruxolitinib versus control therapy
Model Estimates Routine Child Vaccine Doses Missed During 2020
About 8.5 and 8.9 million more children than expected missed routine vaccination for DTP3 and MCV1, respectively, due to COVID-19 pandemic
EHR Use Varies Across Primary Care Specialties
Pediatric clinicians spend less total and after-hours time versus general medicine and family medicine clinicians
Rx Treatment for Opioid Use Disorder Up Among Medicaid Enrollees
There are still considerable gaps in medication care, with Black enrollees having lower use than Whites
U.S. Drug Overdose Deaths Up ~30 Percent in 2020
Increases seen in overdose deaths from opioids, as well as cocaine and psychostimulants
Some Hospitalized COVID-19 Patients Have Ongoing GI Symptoms
Malnutrition is the most persistent GI symptom up to six months following hospitalization
New COVID-19 Cases Doubled in U.S. in Past Three Weeks
As cases climb, health authorities in places such as Los Angeles County and St. Louis are begging even the fully vaccinated to don their masks in public
Rahul Gupta to Be Nominated as Next U.S. Drug Czar
Gupta was the former health commissioner of West Virginia and is chief medical and health officer for the March of Dimes
High-Efficacy Therapy May Reduce Relapses in Active SPMS
But no difference in disability progression seen for high-efficacy versus low-efficacy therapy for secondary progressive multiple sclerosis
Neither Remdesivir Nor HCQ Affect Viral Clearance in COVID-19
No significant difference seen for in-hospital mortality among those receiving remdesivir, hydroxychloroquine, standard of care
